REG - Savills PLC - Director/PDMR Shareholding

SavillsAnnouncement

16/04/2019 15:25

RNS Number : 3783W
Savills PLC
16 April 2019
 


SAVILLS PLC (THE 'COMPANY')
NOTIFICATION OF INTERESTS OF DIRECTORS/ PDMRS
 
Grant of Share Awards
 
The Company announces that on 15 April 2019 the grant of the share based element of 2018 profit share awards has been made under the Savills Deferred Share Bonus Plan to Directors and other persons discharging managerial responsibilities ('PDMR') as follows:-
 



Director/ PDMR


Number of shares subject to the Savills Deferred Share Bonus Plan awarded to the Director / PDMR on

15 April 2019


Resulting beneficial interest under the Savills Deferred Share Bonus Plan and Savills Deferred Share Plan




Mark Ridley (Director)


39,673


134,119




Simon Shaw (Director)


59,182


158,540




Simon Hope (PDMR)


5,449


19,587




Chris Lee (PDMR)


12,643


37,008




Christian Mancini (PDMR)


9,940


26,403




James Sparrow (PDMR)


26,594


44,375



 
The Company announces that on 15 April 2019 the grant of the share based element of 2018 profit share awards has been made under The Schedule to The Savills Deferred Share Bonus Plan to PDMRs based in the United States of America as follows:-
 



PDMR


Number of shares subject to the Savills Deferred Share Bonus Plan awarded to the PDMR on

15 April 2019


Resulting beneficial interest under the Savills Deferred Share Bonus Plan




Mitchell Steir (PDMR)


17,190


34,588



All the above awards have a Deferred Period of three years and are subject to rolled-up dividend shares whereby the number of shares awarded will be increased on the vesting date to reflect final and interim dividends declared during the Deferred Period.
The Company announces that on 15 April 2019 awards have been made under The Savills plc Performance Share Plan (the 'Performance Share Plan') to Directors and PDMRS as follows:- 
 



Director/ PDMR


Number of shares subject to the Performance Share Plan awarded to the Director / PDMR on 15 April 2019


Total number of shares subject to Performance Share Plan Awards following this notification




Mark Ridley (Director)


62,997


161,579




Simon Shaw (Director)


48,174


149,835




Chris Lee (PDMR)


24,523


65,708



The Performance Share Plan provides for the award of nil cost options or conditional awards of ordinary shares in the Company.
Awards of shares are made subject to a three-year performance period.  Awards which satisfy the applicable performance criteria (as below) in the three-year performance period will then vest after an additional two-year holding period for Directors.
Awards vest subject to the satisfaction of the following performance criteria measured over the three years following grant:
(a) 50% of the initial value of an award is subject to the Company's Total Shareholder Return ('TSR') performance measured against the TSR of the FTSE Mid 250 Index (excluding investment trusts);
(b) the other 50% of the initial value of an award is subject to real (i.e. growth in excess of RPI) Group Earnings per Share ('EPS') growth performance.
Awards vest as follows:
(a) for the TSR linked part of an award, 25% (i.e. threshold) will vest if the Company's TSR matches Index performance, rising to 100% (i.e. maximum) if the Company's TSR outperforms the Index by 8% p.a., compound with sliding scale vesting between the two points; and
(b) for the EPS growth linked part of an award, 25% (i.e. threshold) will vest if the Company's real EPS growth (i.e. growth in excess of RPI) is 3% p.a., compound rising to 100% (i.e. maximum) if the Company's real (i.e. growth in excess of RPI) EPS growth is 8% p.a., compound with sliding scale vesting between the two points.
The information set out below is provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation No 596/2014.



1.


Details of the person discharging managerial responsibilities/ person closely associated
 




(a)


Name


1.    Mark Ridley
2.    Simon Shaw
3.    Simon Hope
4.    Chris Lee
5.    Christian Mancini
6.    James Sparrow
7.    Mitchell Steir
 




2.


Reason for the notification
 




(a)


Position/ status


1.    Group Chief Executive/ Director
2.    Group Chief Financial Officer/ Director
3.    Global Head of Capital Markets/ PDMR
4.    Group Legal Director and Company Secretary/ PDMR
5.    Chief Executive Officer Asia Pacific (ex-Greater China) / PDMR
6.    Chief Executive Officer UK & EMEA/ PDMR
7.    Chairman and CEO - Savills North America/ PDMR
 




(b)


Initial notification/ Amendment
 


Initial notification




3.


Details of the issuer
 




(a)


Name


Savills plc
 




(b)


LEI


213800WXICGMBWHTA933
 




4.


Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
 




(a)


Description of the Financial Instrument
 


Awards over Savills plc Ordinary Shares of 2.5p each




(b)


Identification code of the Financial Instrument
 


GB00B135BJ46




(c)


Nature of the transaction
 


Grant of awards over Ordinary Shares in accordance with the Company's Deferred Share Bonus Plan ('DSBP') and Performance Share Plan ('PSP')
 




(d)


Price(s) and volume(s)
 


Price(s)


Volume(s)
 




£nil per share
 


1.    39,673 (DSBP) & 62,997 (PSP)
2.    59,182 (DSBP) & 48,174 (PSP)
3.    5,449 (DSBP)
4.    12,643 (DSBP) & 24,523 (PSP)
5.    9,940 (DSBP)
6.    26,594 (DSBP)
7.    17,190 (DSBP)
 




(e)


Aggregated information
 
-      Aggregated volume
-      Price
 


N/A
 
 




(f)


Date of the transaction
 


15 April 2019




(g)


Place of the transaction
 


Outside a trading venue



 
Name of contact and telephone number for queries:
Chris Lee
Group Legal Director & Company Secretary
020 3107 5444
 
16 April 2019




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHKMGMDMVMGLZM